168 related articles for article (PubMed ID: 22137786)
1. Hydroxycoumarins as selective MAO-B inhibitors.
Serra S; Ferino G; Matos MJ; Vázquez-Rodríguez S; Delogu G; Viña D; Cadoni E; Santana L; Uriarte E
Bioorg Med Chem Lett; 2012 Jan; 22(1):258-61. PubMed ID: 22137786
[TBL] [Abstract][Full Text] [Related]
2. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.
Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L; Viña D
Bioorg Med Chem Lett; 2011 Jul; 21(14):4224-7. PubMed ID: 21684743
[TBL] [Abstract][Full Text] [Related]
3. New halogenated 3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Janeiro P; Borges F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2010 Sep; 20(17):5157-60. PubMed ID: 20659799
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of 6-methyl-3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Picciau C; Orallo F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2009 Sep; 19(17):5053-5. PubMed ID: 19628387
[TBL] [Abstract][Full Text] [Related]
5. New pyrrole inhibitors of monoamine oxidase: synthesis, biological evaluation, and structural determinants of MAO-A and MAO-B selectivity.
La Regina G; Silvestri R; Artico M; Lavecchia A; Novellino E; Befani O; Turini P; Agostinelli E
J Med Chem; 2007 Mar; 50(5):922-31. PubMed ID: 17256833
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and inhibition study of monoamine oxidase, indoleamine 2,3-dioxygenase and tryptophan 2,3-dioxygenase by 3,8-substituted 5H-indeno[1,2-c]pyridazin-5-one derivatives.
Reniers J; Meinguet C; Moineaux L; Masereel B; Vincent SP; Frederick R; Wouters J
Eur J Med Chem; 2011 Dec; 46(12):6104-11. PubMed ID: 22018876
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors.
Reniers J; Robert S; Frederick R; Masereel B; Vincent S; Wouters J
Bioorg Med Chem; 2011 Jan; 19(1):134-44. PubMed ID: 21183355
[TBL] [Abstract][Full Text] [Related]
8. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and molecular modeling of some novel hexahydroindazole derivatives as potent monoamine oxidase inhibitors.
Gökhan-Kelekçi N; Simşek OO; Ercan A; Yelekçi K; Sahin ZS; Işik S; Uçar G; Bilgin AA
Bioorg Med Chem; 2009 Sep; 17(18):6761-72. PubMed ID: 19682910
[TBL] [Abstract][Full Text] [Related]
10. Monoamine oxidase (MAO) inhibitory activity: 3-phenylcoumarins versus 4-hydroxy-3-phenylcoumarins.
Delogu GL; Serra S; Quezada E; Uriarte E; Vilar S; Tatonetti NP; Viña D
ChemMedChem; 2014 Aug; 9(8):1672-6. PubMed ID: 24782464
[TBL] [Abstract][Full Text] [Related]
11. 8-Aryl- and alkyloxycaffeine analogues as inhibitors of monoamine oxidase.
Strydom B; Bergh JJ; Petzer JP
Eur J Med Chem; 2011 Aug; 46(8):3474-85. PubMed ID: 21621312
[TBL] [Abstract][Full Text] [Related]
12. Sulfur-substituted alpha-alkyl phenethylamines as selective and reversible MAO-A inhibitors: biological activities, CoMFA analysis, and active site modeling.
Gallardo-Godoy A; Fierro A; McLean TH; Castillo M; Cassels BK; Reyes-Parada M; Nichols DE
J Med Chem; 2005 Apr; 48(7):2407-19. PubMed ID: 15801832
[TBL] [Abstract][Full Text] [Related]
13. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies.
Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V
Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.
Tripathi RK; Goshain O; Ayyannan SR
ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and inhibitory effect of piperine derivates on monoamine oxidase.
Mu LH; Wang B; Ren HY; Liu P; Guo DH; Wang FM; Bai L; Guo YS
Bioorg Med Chem Lett; 2012 May; 22(9):3343-8. PubMed ID: 22475561
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, molecular modeling studies and selective inhibitory activity against MAO of N1-propanoyl-3,5-diphenyl-4,5-dihydro-(1H)-pyrazole derivatives.
Chimenti F; Fioravanti R; Bolasco A; Manna F; Chimenti P; Secci D; Rossi F; Turini P; Ortuso F; Alcaro S; Cardia MC
Eur J Med Chem; 2008 Oct; 43(10):2262-7. PubMed ID: 18281126
[TBL] [Abstract][Full Text] [Related]
17. Selected C7-substituted chromone derivatives as monoamine oxidase inhibitors.
Legoabe LJ; Petzer A; Petzer JP
Bioorg Chem; 2012 Dec; 45():1-11. PubMed ID: 23064123
[TBL] [Abstract][Full Text] [Related]
18. Monoamine oxidase inhibition by selected anilide derivatives.
Legoabe L; Kruger J; Petzer A; Bergh JJ; Petzer JP
Eur J Med Chem; 2011 Oct; 46(10):5162-74. PubMed ID: 21899930
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in the development of selective human MAO-B inhibitors: (hetero)arylidene-(4-substituted-thiazol-2-yl)hydrazines.
Secci D; Bolasco A; Carradori S; D'Ascenzio M; Nescatelli R; Yáñez M
Eur J Med Chem; 2012 Dec; 58():405-17. PubMed ID: 23153812
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of monoamine oxidase by 8-phenoxymethylcaffeine derivatives.
Okaecwe T; Swanepoel AJ; Petzer A; Bergh JJ; Petzer JP
Bioorg Med Chem; 2012 Jul; 20(14):4336-47. PubMed ID: 22705191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]